Researchers find a promising new approach for treating liver cirrhosis
Aleglitazar improves portal hypertension in rats with cirrhosis by suppressing inflammation, vasoconstriction, and angiogenesis...
List view / Grid view
Aleglitazar improves portal hypertension in rats with cirrhosis by suppressing inflammation, vasoconstriction, and angiogenesis...
10 July 2013 | By Roche
"The safety of patients is our first priority..."